World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page

California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients

by admin | Jan 18, 2018 | News and Opinions

Posted: January 18, 2018 January 18, 2018 – Oakland, CA   Over 650,000 Americans suffer from end-stage kidney disease – a life-threatening condition caused by the loss of kidney function. The best available treatment for these patients is a kidney...
Page 176 of 176« First«...102030...172173174175176

Recent Posts

  • Cracking a ‘holy grail’ challenge in cancer cell therapy
  • New Bio-Implant for Spinal Cord Repair
  • Seattle jury awards $24M in lawsuit against stem cell center
  • Phase I/II study finds intravitreal CD34+ stem cells safe and feasible in CRVO
  • After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
  • More Sensitive Cell Therapy May Be a HIT Against Solid Cancers
World Stem Cell Summit Logo - White version
Copyright © 2026 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow